Sobhani, N.; D’Angelo, A.; Wang, X.; Young, K.H.; Generali, D.; Li, Y.
Mutant p53 as an Antigen in Cancer Immunotherapy. Int. J. Mol. Sci. 2020, 21, 4087.
https://doi.org/10.3390/ijms21114087
AMA Style
Sobhani N, D’Angelo A, Wang X, Young KH, Generali D, Li Y.
Mutant p53 as an Antigen in Cancer Immunotherapy. International Journal of Molecular Sciences. 2020; 21(11):4087.
https://doi.org/10.3390/ijms21114087
Chicago/Turabian Style
Sobhani, Navid, Alberto D’Angelo, Xu Wang, Ken H. Young, Daniele Generali, and Yong Li.
2020. "Mutant p53 as an Antigen in Cancer Immunotherapy" International Journal of Molecular Sciences 21, no. 11: 4087.
https://doi.org/10.3390/ijms21114087
APA Style
Sobhani, N., D’Angelo, A., Wang, X., Young, K. H., Generali, D., & Li, Y.
(2020). Mutant p53 as an Antigen in Cancer Immunotherapy. International Journal of Molecular Sciences, 21(11), 4087.
https://doi.org/10.3390/ijms21114087